Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.

Kawprasertsri S, Pietras RJ, Marquez-Garban DC, Boonyaratanakornkit V. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells. Cancer Lett. 2016 May 01; 374(2):279-91.

View in: PubMed

subject areas

Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Non-Small-Cell Lung
Cell Growth Processes
Cell Line, Tumor
Epidermal Growth Factor
Female
Humans
Lung Neoplasms
Proline-Rich Protein Domains
Receptors, Progesterone
Signal Transduction

authors with profiles

Richard J. Pietras, MD, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support